other material
confidence high
sentiment neutral
materiality 0.50
CalciMedica shareholders approve 1.5M share increase to equity plan; re-elect directors
CalciMedica, Inc.
- Stockholders approved amendment to 2023 Equity Incentive Plan, increasing authorized shares by 1,500,000.
- Eric Bjerkholt and Fred Middleton re-elected as Class I directors for three-year terms.
- Ratified appointment of Moss Adams LLP as independent auditor for fiscal year 2024.
- Record date June 28, 2024; 10,750,156 shares outstanding entitled to vote.